|
1
|
Carosella ED, Favier B, Rouas-Freiss N,
Moreau P and Lemaoult J: Beyond the increasing complexity of the
immunomodulatory HLA-G molecule. Blood. 111:4862–4870. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Amiot L, Ferrone S, Grosse-Wilde H and
Seliger B: Biology of HLA-G in cancer: A candidate molecule for
therapeutic intervention? Cell Mol Life Sci. 68:417–431. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jiang F, Zhao H, Wang L, Guo X, Wang X,
Yin G, Hu Y, Li Y and Yao Y: Role of HLA-G1 in trophoblast cell
proliferation, adhesion and invasion. Biochem Biophys Res Commun.
458:154–160. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rouas-Freiss N, Kirszenbaum M, Dausset J
and Carosella ED: Fetomaternal tolerance: Role of HLA-G molecule in
the protection of the fetus against maternal natural killer
activity. C R Acad Sci III. 320:385–392. 1997.(In French).
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Paul P, Rouas-Freiss N, Khalil-Daher I,
Moreau P, Riteau B, Le Gal FA, Avril MF, Dausset J, Guillet JG and
Carosella ED: HLA-G expression in melanoma: A way for tumor cells
to escape from immunosurveillance. Proc Natl Acad Sci USA. 95:pp.
4510–4515. 1998; View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Castelli EC, Mendes-Junior CT,
Veiga-Castelli LC, Roger M, Moreau P and Donadi EA: A comprehensive
study of polymorphic sites along the HLA-G gene: Implication for
gene regulation and evolution. Mol Biol Evol. 28:3069–3086. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rousseau P, Le Discorde M, Mouillot G,
Marcou C, Carosella ED and Moreau P: The 14 bp deletion-insertion
polymorphism in the 3′ UT region of the HLA-G gene influences HLA-G
mRNA stability. Hum Immunol. 64:1005–1010. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Castelli EC, Mendes-Junior CT, Deghaide
NH, de Albuquerque RS, Muniz YC, Simões RT, Carosella ED, Moreau P
and Donadi EA: The genetic structure of 3′untranslated region of
the HLA-G gene: Polymorphisms and haplotypes. Genes Immun.
11:134–141. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hylenius S, Andersen AM, Melbye M and
Hviid TV: Association between HLA-G genotype and risk of
pre-eclampsia: A case-control study using family triads. Mol Hum
Reprod. 10:237–246. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pandey MK, Rani R and Agrawal S: An update
in recurrent spontaneous abortion. Arch Gynecol Obstet. 272:95–108.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tahan F and Patiroglu T: Plasma soluble
human leukocyte antigen G levels in asthmatic children. Int Arch
Allergy Immunol. 141:213–216. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Consiglio CR, Veit TD, Monticielo OA,
Mucenic T, Xavier RM, Brenol JC and Chies JA: Association of the
HLA-G gene +3142C>G polymorphism with systemic lupus
erythematosus. Tissue Antigens. 77:540–545. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gazit E, Slomov Y, Goldberg I, Brenner S
and Loewenthal R: HLA-G is associated with pemphigus vulgaris in
Jewish patients. Hum Immunol. 65:39–46. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dias FC, Castelli EC, Collares CV, Moreau
P and Donadi EA: The Role of HLA-G molecule and HLA-G gene
polymorphisms in tumors, viral hepatitis, and parasitic diseases.
Front Immunol. 6:92015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Koller BH, Geraghty DE, DeMars R, Duvick
L, Rich SS and Orr HT: Chromosomal organization of the human major
histocompatibility complex class I gene family. J Exp Med.
169:469–480. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Morandi F and Pistoia V: Interactions
between HLA-G and HLA-E in Physiological and Pathological
Conditions. Front Immunol. 5:3942014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Carosella ED, Rouas-Freiss N, Tronik-Le
Roux D, Moreau P and LeMaoult J: HLA-G: An immune checkpoint
molecule. Adv Immunol. 127:33–1444. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Carosella ED, Moreau P, Le Maoult J, Le
Discorde M, Dausset J and Rouas-Freiss N: HLA-G molecules: From
maternal-fetal tolerance to tissue acceptance. Adv Immunol.
81:199–252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fujii T, Ishitani A and Geraghty DE: A
soluble form of the HLA-G antigen is encoded by a messenger
ribonucleic acid containing intron 4. J Immunol. 153:5516–5524.
1994.PubMed/NCBI
|
|
20
|
Park GM, Lee S, Park B, Kim E, Shin J, Cho
K and Ahn K: Soluble HLA-G generated by proteolytic shedding
inhibits NK-mediated cell lysis. Biochem Biophys Res Commun.
313:606–611. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ishitani A and Geraghty DE: Alternative
splicing of HLA-G transcripts yields proteins with primary
structures resembling both class I and class II antigens. Proc Natl
Acad Sci USA. 89:pp. 3947–3951. 1992; View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Curigliano G, Criscitiello C, Gelao L and
Goldhirsch A: Molecular pathways: Human leukocyte antigen G
(HLA-G). Clin Cancer Res. 19:5564–5571. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gao GF, Willcox BE, Wyer JR, Boulter JM,
O'Callaghan CA, Maenaka K, Stuart DI, Jones EY, van der Merwe PA,
Bell JI and Jakobsen BK: Classical and nonclassical class I major
histocompatibility complex molecules exhibit subtle conformational
differences that affect binding to CD8alphaalpha. J Biol Chem.
275:15232–15238. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Colonna M, Samaridis J, Cella M, Angman L,
Allen RL, O'Callaghan CA, Dunbar R, Ogg GS, Cerundolo V and Rolink
A: Human myelomonocytic cells express an inhibitory receptor for
classical and nonclassical MHC class I molecules. J Immunol.
160:3096–3100. 1998.PubMed/NCBI
|
|
25
|
Borges L and Cosman D: LIRs/ILTs/MIRs,
inhibitory and stimulatory Ig-superfamily receptors expressed in
myeloid and lymphoid cells. Cytokine Growth Factor Rev. 11:209–217.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yan WH and Fan LA: Residues Met76 and
Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition. Cell
Res. 15:176–182. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
González A, Rebmann V, LeMaoult J, Horn
PA, Carosella ED and Alegre E: The immunosuppressive molecule HLA-G
and its clinical implications. Crit Rev Clin Lab Sci. 49:63–84.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liang S, Ristich V, Arase H, Dausset J,
Carosella ED and Horuzsko A: Modulation of dendritic cell
differentiation by HLA-G and ILT4 requires the IL-6-STAT3 signaling
pathway. Proc Natl Acad Sci USA. 105:pp. 8357–8362. 2008;
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ketroussi F, Giuliani M, Bahri R, Azzarone
B, Charpentier B and Durrbach A: Lymphocyte cell-cycle inhibition
by HLA-G is mediated by phosphatase SHP-2 and acts on the mTOR
pathway. PLoS One. 6:e227762011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
LeMaoult J, Zafaranloo K, Le Danff C and
Carosella ED: HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in
antigen presenting cells, NK, cells and T cells. FASEB J.
19:662–664. 2005.PubMed/NCBI
|
|
31
|
Gooden MJ and van Hall T: Infiltrating
CTLs are bothered by HLA-E on tumors. Oncoimmunology. 1:92–93.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
LeMaoult J, Krawice-Radanne I, Dausset J
and Carosella ED: HLA-G1-expressing antigen-presenting cells induce
immunosuppressive CD4+ T cells. Proc Natl Acad Sci USA. 101:pp.
7064–7069. 2004; View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ibrahim EC, Aractingi S, Allory Y, Borrini
F, Dupuy A, Duvillard P, Carosella ED, Avril MF and Paul P:
Analysis of HLA antigen expression in benign and malignant
melanocytic lesions reveals that upregulation of HLA-G expression
correlates with malignant transformation, high inflammatory
infiltration and HLA-A1 genotype. Int J Cancer. 108:243–250. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ugurel S, Rebmann V, Ferrone S, Tilgen W,
Grosse-Wilde H and Reinhold U: Soluble human leukocyte antigen-G
serum level is elevated in melanoma patients and is further
increased by interferon-alpha immunotherapy. Cancer. 92:369–376.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
da Silva GB, Silva TG, Duarte RA, Neto NL,
Carrara HH, Donadi EA, Gonçalves MA, Soares EG and Soares CP:
Expression of the Classical and Nonclassical HLA molecules in
breast cancer. Int J Breast Cancer. 2013:2504352013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Elliott RL, Jiang XP, Phillips JT, Barnett
BG and Head JF: Human leukocyte antigen G expression in breast
cancer: Role in immunosuppression. Cancer Biother Radiopharm.
26:153–157. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lefebvre S, Antoine M, Uzan S, McMaster M,
Dausset J, Carosella ED and Paul P: Specific activation of the
non-classical class I histocompatibility HLA-G antigen and
expression of the ILT2 inhibitory receptor in human breast cancer.
J Pathol. 196:266–274. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen HX, Lin A, Shen CJ, Zhen R, Chen BG,
Zhang X, Cao FL, Zhang JG and Yan WH: Upregulation of human
leukocyte antigen-G expression and its clinical significance in
ductal breast cancer. Hum Immunol. 71:892–898. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
He X, Dong DD, Yie SM, Yang H, Cao M, Ye
SR, Li K, Liu J and Chen J: HLA-G expression in human breast
cancer: Implications for diagnosis and prognosis, and effect on
allocytotoxic lymphocyte response after hormone treatment in vitro.
Ann Surg Oncol. 17:1459–1469. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
de Kruijf EM, Sajet A, van Nes JG, Natanov
R, Putter H, Smit VT, Liefers GJ, van den Elsen PJ, van de Velde CJ
and Kuppen PJ: HLA-E and HLA-G expression in classical HLA class
I-negative tumors is of prognostic value for clinical outcome of
early breast cancer patients. J Immunol. 185:7452–7459. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ramos CS, Gonçalves AS, Marinho LC, Gomes
Avelino MA, Saddi VA, Lopes AC, Simões RT and Wastowski IJ:
Analysis of HLA-G gene polymorphism and protein expression in
invasive breast ductal carcinoma. Hum Immunol. 75:667–672. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sayed D, Badr G, Maximous D, Mikhail NN,
Abu-Tarboush F and Alhazza IM: HLA-G and its relation to
proliferation index in detection and monitoring breast cancer
patients. Tissue Antigens. 75:40–47. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jeong S, Park S, Park BW, Park Y, Kwon OJ
and Kim HS: Human leukocyte antigen-G (HLA-G) polymorphism and
expression in breast cancer patients. PLoS One. 9:e982842014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Provatopoulou X, Kalogera E, Sagkriotis A,
Zagouri F, Nonni A, Zografos GC and Gounaris A: Soluble human
leukocyte antigen-G expression in patients with ductal and lobular
breast malignancy. Anticancer Res. 32:1021–1026. 2012.PubMed/NCBI
|
|
45
|
Urosevic M, Kurrer MO, Kamarashev J,
Mueller B, Weder W, Burg G, Stahel RA, Dummer R and Trojan A: Human
leukocyte antigen G up-regulation in lung cancer associates with
high-grade histology, human leukocyte antigen class I loss and
interleukin-10 production. Am J Pathol. 159:817–824. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yie SM, Yang H, Ye SR, Li K, Dong DD and
Lin XM: Expression of human leucocyte antigen G (HLA-G) is
associated with prognosis in non-small cell lung cancer. Lung
Cancer. 58:267–274. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lin A, Zhu CC, Chen HX, Chen BF, Zhang X,
Zhang JG, Wang Q, Zhou WJ, Hu W, Yang HH, et al: Clinical relevance
and functional implications for human leucocyte antigen-g
expression in non-small-cell lung cancer. J Cell Mol Med.
14:2318–2329. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Schütt P, Schütt B, Switala M, Bauer S,
Stamatis G, Opalka B, Eberhardt W, Schuler M, Horn PA and Rebmann
V: Prognostic relevance of soluble human leukocyte antigen-G and
total human leukocyte antigen class I molecules in lung cancer
patients. Hum Immunol. 71:489–495. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Cao M, Yie SM, Liu J, Ye SR, Xia D and Gao
E: Plasma soluble HLA-G is a potential biomarker for diagnosis of
colorectal, gastric, esophageal and lung cancer. Tissue Antigens.
78:120–128. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cai MY, Xu YF, Qiu SJ, Ju MJ, Gao Q, Li
YW, Zhang BH, Zhou J and Fan J: Human leukocyte antigen-G protein
expression is an unfavorable prognostic predictor of hepatocellular
carcinoma following curative resection. Clin Cancer Res.
15:4686–4693. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lin A, Chen HX, Zhu CC, Zhang X, Xu HH,
Zhang JG, Wang Q, Zhou WJ and Yan WH: Aberrant human leucocyte
antigen-G expression and its clinical relevance in hepatocellular
carcinoma. J Cell Mol Med. 14:2162–2171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang Y, Ye Z, Meng XQ and Zheng SS:
Expression of HLA-G in patients with hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int. 10:158–163. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Park Y, Park Y, Lim HS, Kim YS, Hong DJ
and Kim HS: Soluble human leukocyte antigen-G expression in
hepatitis B virus infection and hepatocellular carcinoma. Tissue
Antigens. 79:97–103. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Fukushima Y, Oshika Y, Nakamura M,
Tokunaga T, Hatanaka H, Abe Y, Yamazaki H, Kijima H, Ueyama Y and
Tamaoki N: Increased expression of human histocompatibility
leukocyte antigen-G in colorectal cancer cells. Int J Mol Med.
2:349–351. 1998.PubMed/NCBI
|
|
55
|
Ye SR, Yang H, Li K, Dong DD, Lin XM and
Yie SM: Human leukocyte antigen G expression: As a significant
prognostic indicator for patients with colorectal cancer. Mod
Pathol. 20:375–383. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zeestraten EC, Reimers MS, Saadatmand S,
Goossens-Beumer IJ, Dekker JW, Liefers GJ, van den Elsen PJ, van de
Velde CJ and Kuppen PJ: Combined analysis of HLA class I, HLA-E and
HLA-G predicts prognosis in colon cancer patients. Br J Cancer.
110:459–468. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Guo ZY, Lv YG, Wang L, Shi SJ, Yang F,
Zheng GX, Wen WH and Yang AG: Predictive value of HLA-G and HLA-E
in the prognosis of colorectal cancer patients. Cell Immunol.
293:10–16. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhu CB, Wang CX, Zhang X, Zhang J and Li
W: Serum sHLA-G levels: A useful indicator in distinguishing
colorectal cancer from benign colorectal diseases. Int J Cancer.
128:617–622. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Yie SM, Yang H, Ye SR, Li K, Dong DD and
Lin XM: Expression of human leukocyte antigen G (HLA-G) correlates
with poor prognosis in gastric carcinoma. Ann Surg Oncol.
14:2721–2729. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Du L, Xiao X, Wang C, Zhang X, Zheng N,
Wang L, Zhang X, Li W, Wang S and Dong Z: Human leukocyte antigen-G
is closely associated with tumor immune escape in gastric cancer by
increasing local regulatory T cells. Cancer Sci. 102:1272–1280.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Tuncel T, Karagoz B, Haholu A, Ozgun A,
Emirzeoglu L, Bilgi O and Kandemir EG: Immunoregulatory function of
HLA-G in gastric cancer. Asian Pac J Cancer Prev. 14:7681–7684.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Yie SM, Yang H, Ye SR, Li K, Dong DD and
Lin XM: Expression of HLA-G is associated with prognosis in
esophageal squamous cell carcinoma. Am J Clin Pathol.
128:1002–1009. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lin A, Zhang X, Zhou WJ, Ruan YY, Xu DP,
Wang Q and Yan WH: Human leukocyte antigen-G expression is
associated with a poor prognosis in patients with esophageal
squamous cell carcinoma. Int J Cancer. 129:1382–1390. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Hu J, Li L, Liu Y, Chen Y, Liu C, Liang W,
Zhao J, Zou H, Cui X, Qi Y, et al: Overexpression of HLA-G Is
positively associated with Kazakh esophageal squamous cell
carcinoma in Xinjiang, China. Viral Immunol. 26:180–184. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Zheng J, Xu C, Chu D, Zhang X, Li J, Ji G,
Hong L, Feng Q, Li X, Wu G, et al: Human leukocyte antigen G is
associated with esophageal squamous cell carcinoma progression and
poor prognosis. Immunol Lett. 161:13–19. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Cai MB, Han HQ, Bei JX, Liu CC, Lei JJ,
Cui Q, Feng QS, Wang HY, Zhang JX, Liang Y, et al: Expression of
human leukocyte antigen G is associated with prognosis in
nasopharyngeal carcinoma. Int J Biol Sci. 8:891–900. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Silva TG, Crispim JC, Miranda FA, Hassumi
MK, de Mello JM, Simões RT, Souto F, Soares EG, Donadi EA and
Soares CP: Expression of the nonclassical HLA-G and HLA-E molecules
in laryngeal lesions as biomarkers of tumor invasiveness. Histol
Histopathol. 26:1487–1497. 2011.PubMed/NCBI
|
|
68
|
Gan LH, Huang LF, Zhang X, Lin A, Xu DP,
Wang Q, Wang TJ and Yan WH: Tumor-specific upregulation of human
leukocyte antigen-G expression in bladder transitional cell
carcinoma. Hum Immunol. 71:899–904. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Ibrahim EC, Guerra N, Lacombe MJ, Angevin
E, Chouaib S, Carosella ED, Caignard A and Paul P: Tumor-specific
up-regulation of the nonclassical class I HLA-G antigen expression
in renal carcinoma. Cancer Res. 61:6838–6845. 2001.PubMed/NCBI
|
|
70
|
Kren L, Valkovsky I, Dolezel J, Capak I,
Pacik D, Poprach A, Lakomy R, Redova M, Fabian P, Krenova Z and
Slaby O: HLA-G and HLA-E specific mRNAs connote opposite prognostic
significance in renal cell carcinoma. Diagn Pathol. 7:582012.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Ibrahim EC, Allory Y, Commo F, Gattegno B,
Callard P and Paul P: Altered pattern of major histocompatibility
complex expression in renal carcinoma: Tumor-specific expression of
the nonclassical human leukocyte antigen-G molecule is restricted
to clear cell carcinoma while up-regulation of other major
histocompatibility complex antigens is primarily distributed in all
subtypes of renal carcinoma. Am J Pathol. 162:501–508. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Li BL, Lin A, Zhang XJ, Zhang X, Zhang JG,
Wang Q, Zhou WJ, Chen HX, Wang TJ and Yan WH: Characterization of
HLA-G expression in renal cell carcinoma. Tissue Antigens.
74:213–221. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Li XJ, Zhang X, Lin A, Ruan YY and Yan WH:
Human leukocyte antigen-G (HLA-G) expression in cervical cancer
lesions is associated with disease progression. Hum Immunol.
73:946–949. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Nunes LM, Ayres FM, Francescantonio IC,
Saddi VA, Avelino MA, Alencar Rde C, Silva RC, Meneghini AJ and
Wastowski IJ: Association between the HLA-G molecule and lymph node
metastasis in papillary thyroid cancer. Hum Immunol. 74:447–451.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
de Figueiredo Feitosa NL, Crispim JC,
Zanetti BR, Magalhães PK, Soares CP, Soares EG, Neder L, Donadi EA
and Maciel LM: HLA-G is differentially expressed in thyroid
tissues. Thyroid. 24:585–592. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Morandi F, Levreri I, Bocca P, Galleni B,
Raffaghello L, Ferrone S, Prigione I and Pistoia V: Human
neuroblastoma cells trigger an immunosuppressive program in
monocytes by stimulating soluble HLA-G release. Cancer Res.
67:6433–6441. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Morandi F, Scaruffi P, Gallo F, Stigliani
S, Moretti S, Bonassi S, Gambini C, Mazzocco K, Fardin P, Haupt R,
et al: Bone marrow-infiltrating human neuroblastoma cells express
high levels of calprotectin and HLA-G proteins. PLoS One.
7:e299222012. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Wiendl H, Mitsdoerffer M, Hofmeister V,
Wischhusen J, Bornemann A, Meyermann R, Weiss EH, Melms A and
Weller M: A functional role of HLA-G expression in human gliomas:
An alternative strategy of immune escape. J Immunol. 168:4772–4780.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Kren L, Muckova K, Lzicarova E, Sova M,
Vybihal V, Svoboda T, Fadrus P, Smrcka M, Slaby O, Lakomy R, et al:
Production of immune-modulatory nonclassical molecules HLA-G and
HLA-E by tumor infiltrating ameboid microglia/macrophages in
glioblastomas: A role in innate immunity? J Neuroimmunol.
220:131–135. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Kren L, Slaby O, Muckova K, Lzicarova E,
Sova M, Vybihal V, Svoboda T, Fadrus P, Lakomy R, Vanhara P, et al:
Expression of immune-modulatory molecules HLA-G and HLA-E by tumor
cells in glioblastomas: An unexpected prognostic significance?
Neuropathology. 31:129–134. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Wastowski IJ, Simões RT, Yaghi L, Donadi
EA, Pancoto JT, Poras I, Lechapt-Zalcman E, Bernaudin M, Valable S,
Carlotti CG Jr, et al: Human leukocyte antigen-G is frequently
expressed in glioblastoma and may be induced in vitro by combined
5-aza-2′-deoxycytidine and interferon-γ treatments: Results from a
multicentric study. Am J Pathol. 182:540–552. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Gros F, Sebti Y, de Guibert S, Branger B,
Bernard M, Fauchet R and Amiot L: Soluble HLA-G molecules increase
during acute leukemia, especially in subtypes affecting monocytic
and lymphoid lineages. Neoplasia. 8:223–230. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Dardano A, Rizzo R, Polini A, Stignani M,
Tognini S, Pasqualetti G, Ursino S, Colato C, Ferdeghini M,
Baricordi OR and Monzani F: Soluble human leukocyte antigen-g and
its insertion/deletion polymorphism in papillary thyroid carcinoma:
Novel potential biomarkers of disease? J Clin Endocrinol Metab.
97:4080–4086. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Reimers MS, Engels CC, Putter H, Morreau
H, Liefers GJ, van de Velde CJ and Kuppen PJ; Prognostic value of
HLA class I, HLA-E, HLA-G and Tregs in rectal cancer, : A
retrospective cohort study. Bmc Cancer. 14:4862014. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Martelli-Palomino G, Pancotto JA, Muniz
YC, Mendes-Junior CT, Castelli EC, Massaro JD, Krawice-Radanne I,
Poras I, Rebmann V, Carosella ED, et al: Polymorphic sites at the
3′ untranslated region of the HLA-G gene are associated with
differential hla-g soluble levels in the Brazilian and French
population. PLoS One. 8:e717422013. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Silva ID, Muniz YC, Sousa MC, Silva KR,
Castelli EC, Filho JC, Osta AP, Lima MI and Simões RT: HLA-G 3′UTR
polymorphisms in high grade and invasive cervico-vaginal cancer.
Hum Immunol. 74:452–458. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Jiang Y, Chen S, Jia S, Zhu Z, Gao X, Dong
D and Gao Y: Association of HLA-G 3′ UTR 14-bp insertion/deletion
polymorphism with hepatocellular carcinoma susceptibility in a
Chinese population. Dna Cell Biol. 30:1027–1032. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Lau DT, Norris MD, Marshall GM, Haber M
and Ashton LJ: HLA-G polymorphisms, genetic susceptibility, and
clinical outcome in childhood neuroblastoma. Tissue Antigens.
78:421–427. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Ferguson R, Ramanakumar AV, Koushik A,
Coutlée F, Franco E and Roger M; Biomarkers of Cervical Cancer Risk
Study Team, : Human leukocyte antigen G polymorphism is associated
with an increased risk of invasive cancer of the uterine cervix.
Int J Cancer. 131:E312–E319. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Ghandri N, Gabbouj S, Farhat K, Bouaouina
N, Abdelaziz H, Nouri A, Chouchane L and Hassen E: Association of
HLA-G polymorphisms with nasopharyngeal carcinoma risk and clinical
outcome. Hum Immunol. 72:150–158. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Xu HH, Shi WW, Lin A and Yan WH: HLA-G 3′
untranslated region polymorphisms influence the susceptibility for
human papillomavirus infection. Tissue Antigens. 84:216–222. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Eskandari-Nasab E, Hashemi M, Hasani SS,
Omrani M, Taheri M and Mashhadi MA: Association between HLA-G 3′UTR
14-bp ins/del polymorphism and susceptibility to breast cancer.
Cancer Biomark. 13:253–259. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Rolfsen GB, Castelli EC, Donadi EA, Duarte
RA and Soares CP: HLA-G polymorphism and breast cancer. Int J
Immunogenet. 41:143–148. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Teixeira AC, Mendes-Junior CT, Souza FF,
Marano LA, Deghaide NH, Ferreira SC, Mente ED, Sankarankutty AK,
Elias-Junior J, Castro-e-Silva O, et al: The 14bp-deletion allele
in the HLA-G gene confers susceptibility to the development of
hepatocellular carcinoma in the Brazilian population. Tissue
Antigens. 81:408–413. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Kim SK, Chung JH, Jeon JW, Park JJ, Cha
JM, Joo KR, Lee JI and Shin HP: Association between HLA-G 14-bp
insertion/deletion polymorphism and hepatocellular carcinoma in
Korean patients with chronic hepatitis B viral infection.
Hepatogastroenterology. 60:796–798. 2013.PubMed/NCBI
|
|
96
|
Yan WH: HLA-G expression in cancers:
Potential role in diagnosis, prognosis and therapy. Endocr Metab
Immune Disord Drug Targets. 11:76–89. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Teng MW, Galon J, Fridman WH and Smyth MJ:
From mice to humans: Developments in cancer immunoediting. J Clin
Invest. 125:3338–3346. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Kochan G, Escors D, Breckpot K and
Guerrero-Setas D: Role of non-classical MHC class I molecules in
cancer immunosuppression. Oncoimmunology. 2:e264912013. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Zeng XC, Zhang T, Huang DH, Wang GY, Chen
W, Li H, Zhang J, Fang TL, Zhang Q and Chen GH: RNA interfering
targeting human leukocyte antigen-G enhanced immune surveillance
mediated by the natural killer cells on hepatocellular carcinoma.
Ann Clin Lab Sci. 43:135–144. 2013.PubMed/NCBI
|
|
100
|
Lin A, Xu HH, Xu DP, Zhang X, Wang Q and
Yan WH: Multiple steps of HLA-G in ovarian carcinoma metastasis:
Alter NK cytotoxicity and induce matrix metalloproteinase-15
(MMP-15) expression. Hum Immunol. 74:439–446. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Lesport E, Baudhuin J, LeMaoult J, Sousa
S, Doliger C, Carosella ED and Favier B: Human melanoma cell
secreting human leukocyte antigen-G5 inhibit natural killer cell
cytotoxicity by impairing lytic granules polarization toward target
cell. Hum Immunol. 70:1000–1005. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Moreau P, Mouillot G, Rousseau P, Marcou
C, Dausset J and Carosella ED: HLA-G gene repression is reversed by
demethylation. Proc Natl Acad Sci USA. 100:pp. 1191–1196. 2003;
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Zidi I, Guillard C, Marcou C,
Krawice-Radanne I, Sangrouber D, Rouas-Freiss N, Carosella ED and
Moreau P: Increase in HLA-G1 proteolytic shedding by tumor cells: A
regulatory pathway controlled by NF-kappaB inducers. Cell Mol Life
Sci. 63:2669–2681. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Rodríguez JA, Galeano L, Palacios DM,
Gómez C, Serrano ML, Bravo MM and Combita AL: Altered HLA class I
and HLA-G expression is associated with IL-10 expression in
patients with cervical cancer. Pathobiology. 79:72–83. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Tao S, He H, Chen Q and Yue W: GPER
mediated estradiol reduces miR-148a to promote HLA-G expression in
breast cancer. Biochem Biophys Res Commun. 451:74–78. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Caumartin J, Favier B, Daouya M, Guillard
C, Moreau P, Carosella ED and LeMaoult J: Trogocytosis-based
generation of suppressive NK cells. Embo J. 26:1423–1433. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
LeMaoult J, Caumartin J, Daouya M, Favier
B, Le Rond S, Gonzalez A and Carosella ED: Immune regulation by
pretenders: Cell-to-cell transfers of HLA-G make effector T cells
act as regulatory cells. Blood. 109:2040–2048. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Brown R, Kabani K, Favaloro J, Yang S, Ho
PJ, Gibson J, Fromm P, Suen H, Woodland N, Nassif N, et al: CD86+
or HLA-G+ can be transferred via trogocytosis from myeloma cells to
T cells and are associated with poor prognosis. Blood.
120:2055–2063. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Morandi F, Ferretti E, Bocca P, Prigione
I, Raffaghello L and Pistoia V: A novel mechanism of soluble HLA-G
mediated immune modulation: Downregulation of T cell chemokine
receptor expression and impairment of chemotaxis. PLoS One.
5:e117632010. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Morandi F, Ferretti E, Castriconi R,
Dondero A, Petretto A, Bottino C and Pistoia V: Soluble HLA-G
dampens CD94/NKG2A expression and function and differentially
modulates chemotaxis and cytokine and chemokine secretion in
CD56bright and CD56dim NK cells. Blood. 118:5840–5850. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Naji A, Menier C, Morandi F, Agaugué S,
Maki G, Ferretti E, Bruel S, Pistoia V, Carosella ED and
Rouas-Freiss N: Binding of HLA-G to ITIM-bearing Ig-like transcript
2 receptor suppresses B cell responses. J Immunol. 192:1536–1546.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Liu X, Gu W and Li X: HLA-G regulates the
invasive properties of JEG-3 choriocarcinoma cells by controlling
STAT3 activation. Placenta. 34:1044–1052. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Liang S, Baibakov B and Horuzsko A: HLA-G
inhibits the functions of murine dendritic cells via the PIR-B
immune inhibitory receptor. Eur J Immunol. 32:2418–2426. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Agaugué S, Carosella ED and Rouas-Freiss
N: Role of HLA-G in tumor escape through expansion of
myeloid-derived suppressor cells and cytokinic balance in favor of
Th2 versus Th1/Th17. Blood. 117:7021–7031. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Loumagne L, Baudhuin J, Favier B,
Montespan F, Carosella ED and Rouas-Freiss N: In vivo evidence that
secretion of HLA-G by immunogenic tumor cells allows their evasion
from immunosurveillance. Int J Cancer. 135:2107–2117. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Dong DD, Yie SM, Li K, Li F, Xu Y, Xu G,
Song L and Yang H: Importance of HLA-G expression and tumor
infiltrating lymphocytes in molecular subtypes of breast cancer.
Hum Immunol. 73:998–1004. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Gallegos CE, Michelin S, Trasci SB, Lobos
EA, Dubner D and Carosella ED: HLA-G1 increases the
radiosensitivity of human tumoral cells. Cell Immunol. 287:106–111.
2014. View Article : Google Scholar : PubMed/NCBI
|
